- Clinical Trials
- April 2024
- 50 Pages
Global
From €1457EUR$1,500USD£1,257GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1943EUR$2,000USD£1,676GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1943EUR$2,000USD£1,676GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1943EUR$2,000USD£1,676GBP
- Drug Pipelines
- April 2024
- 50 Pages
Global
From €1457EUR$1,500USD£1,257GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1214EUR$1,250USD£1,047GBP
- Drug Pipelines
- February 2024
- 80 Pages
Global
From €1943EUR$2,000USD£1,676GBP
- Report
- November 2023
- 270 Pages
Global
From €2428EUR$2,500USD£2,095GBP
- Report
- January 2024
- 227 Pages
Global
€4851EUR$4,995USD£4,185GBP
- Report
- January 2024
- 160 Pages
Global
€4851EUR$4,995USD£4,185GBP
- Report
- March 2024
- 180 Pages
Global
From €3277EUR$3,374USD£2,827GBP
€3641EUR$3,749USD£3,141GBP
- Report
- March 2024
- 196 Pages
Global
From €3277EUR$3,374USD£2,827GBP
€3641EUR$3,749USD£3,141GBP
- Report
- March 2024
- 194 Pages
Global
From €3277EUR$3,374USD£2,827GBP
€3641EUR$3,749USD£3,141GBP
- Report
- September 2023
- 81 Pages
Global
From €5779EUR$5,950USD£4,985GBP
- Report
- February 2024
- 175 Pages
Global
From €4856EUR$5,000USD£4,189GBP
- Report
- January 2024
- 175 Pages
Global
From €4856EUR$5,000USD£4,189GBP
- Report
- January 2024
- 175 Pages
Global
From €4856EUR$5,000USD£4,189GBP
- Report
- January 2024
- 175 Pages
Global
From €4856EUR$5,000USD£4,189GBP
- Report
- April 2024
- 175 Pages
Global
From €4856EUR$5,000USD£4,189GBP
- Report
- February 2024
- 250 Pages
Global
From €4856EUR$5,000USD£4,189GBP
The Infectious Diseases Drugs market is a subset of the pharmaceutical industry that focuses on the development and production of drugs used to treat infectious diseases. These drugs are used to treat a wide range of infections, including bacterial, viral, fungal, and parasitic infections. The market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing treatments. Additionally, many companies are involved in the production of generic drugs, which are often cheaper than brand-name drugs.
Companies in the Infectious Diseases Drugs market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, Johnson & Johnson, and Bristol-Myers Squibb. Show Less Read more